These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21375716)

  • 1. Metabolism of a plant derived galactose-containing polysaccharide by Bifidobacterium breve UCC2003.
    O'Connell Motherway M; Fitzgerald GF; van Sinderen D
    Microb Biotechnol; 2011 May; 4(3):403-16. PubMed ID: 21375716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003.
    O'Connell Motherway M; Kinsella M; Fitzgerald GF; van Sinderen D
    Microb Biotechnol; 2013 Jan; 6(1):67-79. PubMed ID: 23199239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of the galactan utilization system of Geobacillus stearothermophilus.
    Tabachnikov O; Shoham Y
    FEBS J; 2013 Feb; 280(3):950-64. PubMed ID: 23216604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ApuB, an extracellular type II amylopullulanase from Bifidobacterium breve UCC2003.
    O'Connell Motherway M; Fitzgerald GF; Neirynck S; Ryan S; Steidler L; van Sinderen D
    Appl Environ Microbiol; 2008 Oct; 74(20):6271-9. PubMed ID: 18689518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the ganSPQAB Operon in Degradation of Galactan by Bacillus subtilis.
    Watzlawick H; Morabbi Heravi K; Altenbuchner J
    J Bacteriol; 2016 Oct; 198(20):2887-96. PubMed ID: 27501980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation and characterization of a novel beta-fructofuranosidase-encoding gene from Bifidobacterium breve UCC2003.
    Ryan SM; Fitzgerald GF; van Sinderen D
    Appl Environ Microbiol; 2005 Jul; 71(7):3475-82. PubMed ID: 16000751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifidobacterium longum endogalactanase liberates galactotriose from type I galactans.
    Hinz SW; Pastink MI; van den Broek LA; Vincken JP; Voragen AG
    Appl Environ Microbiol; 2005 Sep; 71(9):5501-10. PubMed ID: 16151143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellodextrin utilization by bifidobacterium breve UCC2003.
    Pokusaeva K; O'Connell-Motherway M; Zomer A; Macsharry J; Fitzgerald GF; van Sinderen D
    Appl Environ Microbiol; 2011 Mar; 77(5):1681-90. PubMed ID: 21216899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a fructose phosphotransferase system in Bifidobacterium breve UCC2003.
    Mazé A; O'Connell-Motherway M; Fitzgerald GF; Deutscher J; van Sinderen D
    Appl Environ Microbiol; 2007 Jan; 73(2):545-53. PubMed ID: 17098914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of biosynthetic oligosaccharides by human-derived Bifidobacterium breve UCC2003 and Bifidobacterium longum NCIMB 8809.
    Ruiz-Aceituno L; Esteban-Torres M; James K; Moreno FJ; van Sinderen D
    Int J Food Microbiol; 2020 Mar; 316():108476. PubMed ID: 31874325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct substrate specificities of three glycoside hydrolase family 42 β-galactosidases from Bifidobacterium longum subsp. infantis ATCC 15697.
    Viborg AH; Katayama T; Abou Hachem M; Andersen MC; Nishimoto M; Clausen MH; Urashima T; Svensson B; Kitaoka M
    Glycobiology; 2014 Feb; 24(2):208-16. PubMed ID: 24270321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of sialic acid by Bifidobacterium breve UCC2003.
    Egan M; O'Connell Motherway M; Ventura M; van Sinderen D
    Appl Environ Microbiol; 2014 Jul; 80(14):4414-26. PubMed ID: 24814790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribose utilization by the human commensal Bifidobacterium breve UCC2003.
    Pokusaeva K; Neves AR; Zomer A; O'Connell-Motherway M; MacSharry J; Curley P; Fitzgerald GF; van Sinderen D
    Microb Biotechnol; 2010 May; 3(3):311-23. PubMed ID: 21255330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved two-component signal transduction system controls the response to phosphate starvation in Bifidobacterium breve UCC2003.
    Alvarez-Martin P; Fernández M; O'Connell-Motherway M; O'Connell KJ; Sauvageot N; Fitzgerald GF; MacSharry J; Zomer A; van Sinderen D
    Appl Environ Microbiol; 2012 Aug; 78(15):5258-69. PubMed ID: 22635988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in Bifidobacterium breve UCC2003.
    O'Connell Motherway M; O'Driscoll J; Fitzgerald GF; Van Sinderen D
    Microb Biotechnol; 2009 May; 2(3):321-32. PubMed ID: 21261927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GntR-type transcriptional repressor controls sialic acid utilization in Bifidobacterium breve UCC2003.
    Egan M; O'Connell Motherway M; van Sinderen D
    FEMS Microbiol Lett; 2015 Feb; 362(4):. PubMed ID: 25688064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription of two adjacent carbohydrate utilization gene clusters in Bifidobacterium breve UCC2003 is controlled by LacI- and repressor open reading frame kinase (ROK)-type regulators.
    O'Connell KJ; Motherway MO; Liedtke A; Fitzgerald GF; Paul Ross R; Stanton C; Zomer A; van Sinderen D
    Appl Environ Microbiol; 2014 Jun; 80(12):3604-14. PubMed ID: 24705323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of four α-glycosidic linkage-containing oligosaccharides by Bifidobacterium breve UCC2003.
    O'Connell KJ; O'Connell Motherway M; O'Callaghan J; Fitzgerald GF; Ross RP; Ventura M; Stanton C; van Sinderen D
    Appl Environ Microbiol; 2013 Oct; 79(20):6280-92. PubMed ID: 23913435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-component regulatory system controls autoregulated serpin expression in Bifidobacterium breve UCC2003.
    Alvarez-Martin P; O'Connell Motherway M; Turroni F; Foroni E; Ventura M; van Sinderen D
    Appl Environ Microbiol; 2012 Oct; 78(19):7032-41. PubMed ID: 22843530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacterium longum subsp. longum Exo-β-1,3-Galactanase, an enzyme for the degradation of type II arabinogalactan.
    Fujita K; Sakaguchi T; Sakamoto A; Shimokawa M; Kitahara K
    Appl Environ Microbiol; 2014 Aug; 80(15):4577-84. PubMed ID: 24837371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.